StockNews.com began coverage on shares of VBI Vaccines (NASDAQ:VBIV – Get Free Report) in a research report issued on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock.
VBI Vaccines Trading Up 1.6 %
Shares of VBI Vaccines stock opened at $0.60 on Friday. VBI Vaccines has a 12-month low of $0.45 and a 12-month high of $3.47. The firm has a market capitalization of $17.04 million, a price-to-earnings ratio of -0.05 and a beta of 1.93. The firm’s 50 day simple moving average is $0.61 and its two-hundred day simple moving average is $0.61.
VBI Vaccines Company Profile
Featured Articles
- Five stocks we like better than VBI Vaccines
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Hasbro’s Management Made All the Right Calls This Quarter
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Best Stocks Under $5.00
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for VBI Vaccines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VBI Vaccines and related companies with MarketBeat.com's FREE daily email newsletter.